Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith L Ligon

Showing results (1-10 of 324) with videos related to

Pageof 33
Sort By:
Neuro-Oncology|April 6, 2021
Prognostication for meningiomas: H3K27me3 to the rescue?Sandro Santagata, Keith L Ligon
Neuro-Oncology|October 25, 2014
Molecular pathologic diagnosis of epidermal growth factor receptorCecile L Maire, Keith L Ligon
Cancer Cell|March 15, 2011
Glioma models: new GEMMs add "class" with genomic and expression correlationsCécile L Maire, Keith L Ligon
The American Journal of Surgical Pathology|November 24, 2006
Comparative analysis of germ cell transcription factors in CNS germinoma reveals diagnostic utility of NANOGSandro Santagata, Jason L Hornick, Keith L Ligon
The American Journal of Surgical Pathology|May 29, 2007
Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumorsSandro Santagata, Keith L Ligon, Jason L Hornick
Brain Pathology (Zurich, Switzerland)|June 17, 2025
Integration of omics data in the diagnosis and therapy of glioblastomaConstantin Möller, Melanie Schoof, Keith L Ligon, et al.
Current Opinion in Oncology|October 15, 2021
Mutational burden and immune recognition of gliomasDiego Prost, Franck Bielle, Keith L Ligon, et al.
Neuro-Oncology|August 19, 2025
Revisiting an old therapy for new, promising combinations: biology and perspectives of lomustine in glioma treatmentCharlotte Bellamy, Cynthia Hajal, Keith L Ligon, et al.
Expert Review of Anticancer Therapy|April 27, 2013
Enhancing radiation therapy for patients with glioblastomaBrian M Alexander, Keith L Ligon, Patrick Y Wen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2025
Genomic Profiling Reveals SMARCA4 Mutations Are Associated with Shorter Overall and Intracranial Progression-Free Survival in Patients with Melanoma Brain MetastasesGrant M Fischer, Nayan Lamba, Jayne Vogelzang, et al.
Pageof 33

Showing results (1-10 of 324) with videos related to

Sort By:
Pageof 33
Neuro-Oncology|April 6, 2021
Prognostication for meningiomas: H3K27me3 to the rescue?Sandro Santagata, Keith L Ligon
Neuro-Oncology|October 25, 2014
Molecular pathologic diagnosis of epidermal growth factor receptorCecile L Maire, Keith L Ligon
Cancer Cell|March 15, 2011
Glioma models: new GEMMs add "class" with genomic and expression correlationsCécile L Maire, Keith L Ligon
The American Journal of Surgical Pathology|November 24, 2006
Comparative analysis of germ cell transcription factors in CNS germinoma reveals diagnostic utility of NANOGSandro Santagata, Jason L Hornick, Keith L Ligon
The American Journal of Surgical Pathology|May 29, 2007
Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumorsSandro Santagata, Keith L Ligon, Jason L Hornick
Brain Pathology (Zurich, Switzerland)|June 17, 2025
Integration of omics data in the diagnosis and therapy of glioblastomaConstantin Möller, Melanie Schoof, Keith L Ligon, et al.
Current Opinion in Oncology|October 15, 2021
Mutational burden and immune recognition of gliomasDiego Prost, Franck Bielle, Keith L Ligon, et al.
Neuro-Oncology|August 19, 2025
Revisiting an old therapy for new, promising combinations: biology and perspectives of lomustine in glioma treatmentCharlotte Bellamy, Cynthia Hajal, Keith L Ligon, et al.
Expert Review of Anticancer Therapy|April 27, 2013
Enhancing radiation therapy for patients with glioblastomaBrian M Alexander, Keith L Ligon, Patrick Y Wen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2025
Genomic Profiling Reveals SMARCA4 Mutations Are Associated with Shorter Overall and Intracranial Progression-Free Survival in Patients with Melanoma Brain MetastasesGrant M Fischer, Nayan Lamba, Jayne Vogelzang, et al.
Pageof 33